Cloud Banner
Home Healthcare global-plasma-fractionational-market

Healthcare

Image

Global Plasma Fractionation Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Jul 2021
  • Global
  • 350 Pages
  • No of Tables: 317
  • No of Figures: 73

Global Plasma Fractionation Market, By Product Type (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors and Other Products), Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato- Oncology, Rheumatology and Others),  Processing Technology (Ion- Exchange Chromatography , Affinity Chromatography, Cryopreservation, Ultrafiltration and Microfiltration), Mode (Modern Plasma Fractionation and Traditional Plasma Fractionation), End User (Hospitals & Clinics, Clinical Research Laboratories Academic Institutions and Others), Distribution Channel (Direct Tenders, Third Party Distribution and Others) , Country (U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Switzerland, Netherlands, Russia, Turkey, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

Plasma Fractionation Market Market Analysis and Insights: Global Plasma Fractionation Market

Global plasma fractionation market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.5% in the forecast period of 2021 to 2028 and is expected to reach USD 40,088.69 million by 2028. High presence of number of plasma collection centres are helping in growing demand of the plasma fractionation market.

Plasma is a blood component that derives from whole blood by plasmapheresis and is used for various therapeutic and medical applications. Human plasma is s source of numerous different proteins. However, only few of these proteins are useful for producing therapeutic plasma products. The process of separation, extraction and purification of these proteins from the plasma is called fractionation process.

Global plasma fractionation market is growing with factors such as rise in respiratory diseases across the world, increase in aging population with blood-related ailments and increasing usage of immunoglobulins. Increase in rare diseases that require the use of plasma therapy or plasma derivatives also acts as a major factor for the growth of the market. Increasing investment in research and development has also given a boom to the global plasma fractionation market.

However, the stringent government regulations regarding the plasma therapies are restraining the growth of plasma fractionation market. Additionally, the shortage of plasma proteins acts as a hindrance towards the growth of the market.

This plasma fractionation market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Plasma Fractionation MarketGlobal Plasma Fractionation Market Scope and Market Size

Global plasma fractionation market is segmented into six notable segments which are based on the product type, application, processing technology, mode, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the plasma fractionation market is segmented into immunoglobulins, coagulation factor concentrate, albumin, protease inhibitors and other products. In 2021, immunoglobulin has the largest market share owing to the factors such as the high number of health benefits associated with immunomodulatory actions.

  • On the basis of application, the plasma fractionation market is segmented into neurology, immunology, haematology, critical care, pulmonology, hemato- oncology, rheumatology and others. In 2021, immunology has the largest market share owing to the factors such as increasing usage of plasma proteins in the treatment of immune deficiencies.

  • On the basis of processing technology, the plasma fractionation market is segmented into Ion- exchange chromatography, affinity chromatography, cryopreservation, ultrafiltration and microfiltration. In 2021, Ion- exchange chromatography has the largest market share owing to the factor such as the high purification capability using ions by removing inorganic substances.

  • On the basis of mode, the plasma fractionation market is segmented into modern plasma fraction and traditional plasma fractionation. In 2021, modern plasma fractions has the largest market share owing to the factors such as the employing the state of art equipment and production facilities for the plasma fractionation process.

  • On the basis of end user, the plasma fractionation market is segmented into Hospitals & clinics, clinical research laboratories academic institutions and others. In 2021, hospitals & clinics  has the largest market share due to improving infrastructure and health care facilities provided by hospitals, along with increasing off- label use of plasma fractionated products in hospitals to treat various diseases..

  • On the basis of distribution channel, the plasma fractionation market is segmented into direct tenders, third party distribution and others. In 2021, direct tenders have the largest market share due to increasing distribution through direct tenders from the manufacturers to the health care workers.

Plasma Fractionation MarketGlobal Plasma Fractionation Market: Country Level Analysis

Global plasma fractionation market is analysed and market size information is provided by country, product type, application, processing technology, mode, end user and distribution channel as referenced above.

The countries covered in the global plasma fractionation market report are U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Switzerland, Netherlands, Russia, Turkey, rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel and rest of Middle East and Africa.

North America holds the largest market share in the global plasma fractionation market due to increasing incidences of usage of plasma fractionated products and increasing innovative product developments.

  • In, North America, U.S. is dominating in the global plasma fractionation market with the highest CAGR as the region has more awareness about the extensive benefits of the plasma. In Asia-Pacific, China is dominating in the global plasma fractionation market due to increase in the demand for Plasma Fractionation and growing concern over the human health. While in Europe, Germany is dominating the market with the highest share due to the geriatric population and immune deficiency diseases.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising Demand of Plasma Fractionation

Global plasma fractionation market also provides you with detailed market analysis for every country growth in industry with sales, components sales, impact of technological development in plasma fractionation and changes in regulatory scenarios with their support for the plasma fractionation product market. The data is available for historic period 2010-2019.

Competitive Landscape and Global Plasma Fractionation Market Share Analysis

Global plasma fractionation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, India presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global plasma fractionation market.

Some of the major players operating in the plasma fractionation market are Grifols, S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, CSL Plasma, Japan Blood Products Organization, China Biologic Products Holdings, Inc., LFB SA, Green Cross Corp., Shanghai RAAS, Baxter, Bio Products Laboratory Ltd., Novasep Holding SAS, Pall Corporation, KabaFusion, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Bharat Serums and Vaccines Limited (BSV), SK Plasma, Kedrion S.p.A, Sanquin, Biotest AG, Merck KGaA, ADMA Biologics, Inc., Boccard, Intas Pharmaceuticals Ltd. and CENTURION Ilaç Sanayi ve Ticaret A.S. among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches are also initiated by the companies worldwide which are also accelerating the growth of global plasma fractionation market.

For instance,

  • In April 2020, Grifols launched 3- ml vial for Hyper RAB which is rabies immune globulin in the plasma fractionation market to help in the treatment of rabies cases across the world.

Collaboration, joint ventures and other strategies by the market players is enhancing the company footprints in the Plasma Fractionation market which also provides the benefit for organisation in its growth pace.

SKU-

TABLE 1 GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 2 GLOBAL IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 GLOBAL IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 4 GLOBAL COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 GLOBAL COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 6 GLOBAL ALBUMIN IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 GLOBAL PROTEASE INHIBITORS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 GLOBAL OTHER PRODUCTS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 GLOBAL PLASMA FRACTIONATION MARKET, APPLICATION, 2019-2028 (USD MILLION)

TABLE 10 GLOBAL IMMUNOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 GLOBAL HAEMATOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 GLOBAL CRITICAL CARE IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 GLOBAL NEUROLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 GLOBAL PULMONOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 GLOBAL HAEMATO-ONCOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 GLOBAL RHEUMATOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 GLOBAL OTHER APPLICATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 GLOBAL PLASMA FRACTIONATION MARKET, PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 19 GLOBAL ION-EXCHANGE CHROMATOGRAPHY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 GLOBAL AFFINITY CHROMATOGRAPHY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 GLOBAL ULTRAFILTRATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 GLOBAL MICROFILTRATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 GLOBAL CRYOPRECIPITATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 GLOBAL PLASMA FRACTIONATION MARKET, MODE, 2019-2028 (USD MILLION)

TABLE 25 GLOBAL MODERN PLASMA FRACTIONATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 GLOBAL TRADITIONAL PLASMA FRACTIONATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 GLOBAL PLASMA FRACTIONATION MARKET, END USER, 2019-2028 (USD MILLION)

TABLE 28 GLOBAL HOSPITALS & CLINICS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 GLOBAL CLINICAL RESEARCH LABORATORIES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 GLOBAL ACADEMIC INSTITUTES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 GLOBAL OTHERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 GLOBAL PLASMA FRACTIONATION MARKET, DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 33 GLOBAL DIRECT TENDERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 GLOBAL THIRD PARTY DISTRIBUTION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 GLOBAL OTHERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 GLOBAL PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 41 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 42 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 43 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 44 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 45 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 46 U.S. PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 47 U.S. IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 48 U.S. COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 49 U.S. PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 50 U.S. PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 51 U.S. PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 52 U.S. PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 53 U.S. PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 54 CANADA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 55 CANADA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 56 CANADA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 57 CANADA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 58 CANADA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 59 CANADA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 60 CANADA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 61 CANADA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 62 MEXICO PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 63 MEXICO IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 64 MEXICO COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 65 MEXICO PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 66 MEXICO PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 67 MEXICO PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 68 MEXICO PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 69 MEXICO PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 70 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 71 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 72 ASIA-PACIFIC IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 73 ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 74 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 75 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 76 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 77 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 78 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 79 CHINA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 80 CHINA IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 81 CHINA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 82 CHINA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 83 CHINA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 84 CHINA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 85 CHINA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 86 CHINA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 87 JAPAN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 88 JAPAN IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 89 JAPAN COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 90 JAPAN PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 91 JAPAN PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 92 JAPAN PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 93 JAPAN PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 94 JAPAN PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 95 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 96 SOUTH KOREA IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 97 SOUTH KOREA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 98 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 99 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 100 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 101 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 102 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 103 AUSTRALIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 104 AUSTRALIA IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 105 AUSTRALIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 106 AUSTRALIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 107 AUSTRALIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 108 AUSTRALIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 109 AUSTRALIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 110 AUSTRALIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 111 INDIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 112 INDIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 113 INDIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 114 INDIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 115 INDIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 116 INDIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 117 INDIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 118 INDIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 119 MALAYSIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 120 MALAYSIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 121 MALAYSIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 122 MALAYSIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 123 MALAYSIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 124 MALAYSIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 125 MALAYSIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 126 MALAYSIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 127 THAILAND PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 128 THAILAND IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 129 THAILAND COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 130 THAILAND PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 131 THAILAND PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 132 THAILAND PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 133 THAILAND PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 134 THAILAND PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 135 SINGAPORE PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 136 SINGAPORE IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 137 SINGAPORE COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 138 SINGAPORE PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 139 SINGAPORE PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 140 SINGAPORE PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 141 SINGAPORE PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 142 SINGAPORE PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 143 PHILIPPINES PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 144 PHILIPPINES IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 145 PHILIPPINES COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 146 PHILIPPINES PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 147 PHILIPPINES PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 148 PHILIPPINES PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 149 PHILIPPINES PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 150 PHILIPPINES PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 151 INDONESIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 152 INDONESIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 153 INDONESIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 154 INDONESIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 155 INDONESIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 156 INDONESIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 157 INDONESIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 158 INDONESIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 159 REST OF ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 160 EUROPE PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 161 EUROPE PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 162 EUROPE IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 163 EUROPE COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 164 EUROPE PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 165 EUROPE PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 166 EUROPE PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 167 EUROPE PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 168 EUROPE PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 169 GERMANY PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 170 GERMANY IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 171 GERMANY COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 172 GERMANY PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 173 GERMANY PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 174 GERMANY PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 175 GERMANY PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 176 GERMANY PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 177 FRANCE PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 178 FRANCE IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 179 FRANCE COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 180 FRANCE PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 181 FRANCE PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 182 FRANCE PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 183 FRANCE PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 184 FRANCE PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 185 U.K. PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 186 U.K. IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 187 U.K. COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 188 U.K. PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 189 U.K. PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 190 U.K. PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 191 U.K. PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 192 U.K. PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 193 ITALY PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 194 ITALY IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 195 ITALY COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 196 ITALY PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 197 ITALY PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 198 ITALY PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 199 ITALY PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 200 ITALY PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 201 SPAIN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 202 SPAIN IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 203 SPAIN COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 204 SPAIN PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 205 SPAIN PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 206 SPAIN PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 207 SPAIN PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 208 SPAIN PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 209 RUSSIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 210 RUSSIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 211 RUSSIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 212 RUSSIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 213 RUSSIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 214 RUSSIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 215 RUSSIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 216 RUSSIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 217 TURKEY PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 218 TURKEY IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 219 TURKEY COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 220 TURKEY PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 221 TURKEY PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 222 TURKEY PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 223 TURKEY PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 224 TURKEY PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 225 NETHERLANDS PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 226 NETHERLANDS IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 227 NETHERLANDS COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 228 NETHERLANDS PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 229 NETHERLANDS PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 230 NETHERLANDS PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 231 NETHERLANDS PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 232 NETHERLANDS PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 233 SWITZERLAND PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 234 SWITZERLAND IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 235 SWITZERLAND COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 236 SWITZERLAND PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 237 SWITZERLAND PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 238 SWITZERLAND PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 239 SWITZERLAND PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 240 SWITZERLAND PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 241 REST OF EUROPE PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 242 SOUTH AMERICA PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 243 SOUTH AMERICA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 244 SOUTH AMERICA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 245 SOUTH AMERICA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 246 SOUTH AMERICA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 247 SOUTH AMERICA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 248 SOUTH AMERICA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 249 SOUTH AMERICA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 250 SOUTH AMERICA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 251 BRAZIL PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 252 BRAZIL IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 253 BRAZIL COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 254 BRAZIL PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 255 BRAZIL PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 256 BRAZIL PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 257 BRAZIL PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 258 BRAZIL PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 259 ARGENTINA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 260 ARGENTINA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 261 ARGENTINA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 262 ARGENTINA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 263 ARGENTINA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 264 ARGENTINA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 265 ARGENTINA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 266 ARGENTINA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 267 REST OF SOUTH AMERICA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 268 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 269 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 270 MIDDLE EAST AND AFRICA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 271 MIDDLE EAST AND AFRICA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 272 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 273 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 274 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 275 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 276 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 277 SOUTH AFRICA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 278 SOUTH AFRICA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 279 SOUTH AFRICA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 280 SOUTH AFRICA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 281 SOUTH AFRICA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 282 SOUTH AFRICA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 283 SOUTH AFRICA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 284 SOUTH AFRICA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 285 SAUDI ARABIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 286 SAUDI ARABIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 287 SAUDI ARABIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 288 SAUDI ARABIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 289 SAUDI ARABIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 290 SAUDI ARABIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 291 SAUDI ARABIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 292 SAUDI ARABIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 293 U.A.E. PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 294 U.A.E. IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 295 U.A.E. COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 296 U.A.E. PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 297 U.A.E. PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 298 U.A.E. PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 299 U.A.E. PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 300 U.A.E. PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 301 ISRAEL PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 302 ISRAEL IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 303 ISRAEL COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 304 ISRAEL PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 305 ISRAEL PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 306 ISRAEL PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 307 ISRAEL PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 308 ISRAEL PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 309 EGYPT PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 310 EGYPT IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 311 EGYPT COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 312 EGYPT PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 313 EGYPT PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 314 EGYPT PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 315 EGYPT PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 316 EGYPT PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 317 REST OF MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

Plasma Fractionation Market is growing with a CAGR of 6.5% by 2028
Plasma Fractionation Market is expected to reach USD 40,088.69 million by 2028
the major players operating in the plasma fractionation market are Grifols, S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, CSL Plasma, Japan Blood Products Organization, China Biologic Products Holdings, Inc., LFB SA, Green Cross Corp., Shanghai RAAS, Baxter, Bio Products Laboratory Ltd., Novasep Holding SAS, Pall Corporation, KabaFusion, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Bharat Serums and Vaccines Limited (BSV), SK Plasma, Kedrion S.p.A, Sanquin, Biotest AG, Merck KGaA, ADMA Biologics, Inc., Boccard, Intas Pharmaceuticals Ltd. and CENTURION İlaç Sanayi ve Ticaret A.Ş. among others.
In Asia-Pacific, China is dominating in the global plasma fractionation market due to increase in the demand for Plasma Fractionation and growing concern over the human health. While in Europe, Germany is dominating the market with the highest share due to the geriatric population and immune deficiency diseases.

BROWSE RELATED Blogs

Global Plasma Fractionation Market is Growing with 6.5% CAGR in the Forecast Period of 2021 to 2028

BROWSE RELATED Press Release

According to WHO, there are About 13,300 Blood Centers in 169 Countries that Report Collecting a Total of 106 Million Donations
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Can be used by entire organization across the globe + Downloadable and Printable PDF + 30 + Countries

Buy Now
Request for TOC Speak to Analyst Inquire Before Buying Free Sample Report
Advance Formative Research Customization Request for bulk Reports

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials

David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Image
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Image
Business Intelligence and Analytics,
Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst,
Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director,
Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO,
A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director,
Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager,
Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations,
GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst,
Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager,
Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment
MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer
Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro
Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future

Reports

Market Insights

Support

Solutions

DMCA Protected © DataBridge - All Rights Reserved. Payment

Suggested Searches